Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TRIO and F-actin-binding protein (TRIOBP) is a human protein encoded by the TRIOBP gene. It binds directly to filamentous F-actin, stabilizing F-actin structures and playing a critical role in the regulation of the actin cytoskeleton, cell motility, and growth. TRIOBP interacts with Trio, a protein involved in neural tissue development, and is essential for the correct progression of mitosis and the formation of stereocilia rootlets in the inner ear. Mutations in TRIOBP are associated with hereditary forms of deafness, particularly autosomal recessive nonsyndromic deafness type DFNB28. Multiple isoforms exist due to alternative splicing, with some transcripts possibly subject to nonsense-mediated decay[1][2][4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TRIO and F-actin-binding protein (TRIOBP).